Larvol Delta - Inhibikase-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-Risvodetinib-for-the-Treatment-of-Multiple-System-Atrophy

risvodetinib (IkT-148009) - Inhibikase, Clintrex

https://www.globenewswire.com/news-release/2023/10/04/2754577/0/en/Inhibikase-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-Risvodetinib-for-the-Treatment-of-Multiple-System-Atrophy.html

Oct 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next